Literature DB >> 11992567

Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases.

Nobuto Shibata1, Tohru Ohnuma, Tadashi Takahashi, Hajime Baba, Takuya Ishizuka, Mieko Ohtsuka, Akira Ueki, Masatsugu Nagao, Heii Arai.   

Abstract

Interleukin-6 (IL-6), an inflammatory cytokine might be involved in the pathophysiology of Alzheimer disease (AD); several studies have reported that the "C allele of IL-6 variable number of tandem repeat polymorphism" (IL-6vntr) delayed initial onset of AD and also decreased its risk per se. Another polymorphism, G/C allele of IL-6 gene promoter region (IL-6prom), is also a candidate because it has an influence on the regulation of plasma IL-6 concentration. We examined these IL-6 polymorphisms in 128 Japanese AD cases and 83 control cases using a PCR-RFLP method. The results showed the frequency of the IL-6prom G allele was significantly increased in AD, although IL-6vntr polymorphism was not. Plasma IL-6 concentration of the AD cases was also significantly higher than that of the control cases. Moreover, the IL-6prom G allele-positive AD patients showed a tendency to have higher IL-6 concentration in the AD group. These findings suggest that the IL-6prom G allele which may affect plasma IL-6 concentration might be a risk factor for sporadic AD in Japanese. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992567     DOI: 10.1002/ajmg.10417

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  18 in total

1.  Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer's disease risk.

Authors:  Onofre Combarros; Jon Infante; Javier Llorca; Nicolás Peña; Carlos Fernández-Viadero; José Berciano
Journal:  J Neurol       Date:  2005-03-22       Impact factor: 4.849

2.  RFLP readout introduces a type I error in meta-analysis of IL-6.

Authors:  Philipp G Sand
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 4.849

3.  Relationships between genetic polymorphisms in inflammation-related factor gene and the pathogenesis of nasopharyngeal cancer.

Authors:  Yan-Li Qu; Hong Yu; Yan-Zhi Chen; Yu-Xia Zhao; Guang-Jun Chen; Lu Bai; Dan Liu; Hong-Xin Su; He-Tong Wang
Journal:  Tumour Biol       Date:  2014-06-22

Review 4.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

Review 5.  Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: a meta-analysis.

Authors:  Limeng Dai; Dan Liu; Hong Guo; Yanyan Wang; Yun Bai
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

6.  Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease.

Authors:  Mei-xia He; Wan-li Yang; Ming-ming Zhang; Ya-jun Lian; Hai-ying Hua; Jin-sheng Zeng; Li-rong Zhang
Journal:  Neurol Sci       Date:  2009-12-03       Impact factor: 3.307

7.  Pharmacogenetic Study on the Impact of Rivastigmine Concerning Genetic Variants of A2M and IL-6 Genes on Iranian Alzheimer's Patients.

Authors:  Mahdi Zamani; Masomeh Mohammadi; Hamid Zamani; Alireza Tavasoli
Journal:  Mol Neurobiol       Date:  2015-08-21       Impact factor: 5.590

8.  Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis.

Authors:  Mingyuan Yang; Chao Li; Ming Li
Journal:  Biomed Rep       Date:  2014-06-16

9.  Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition.

Authors:  Paramita Chakrabarty; Karen Jansen-West; Amanda Beccard; Carolina Ceballos-Diaz; Yona Levites; Christophe Verbeeck; Abba C Zubair; Dennis Dickson; Todd E Golde; Pritam Das
Journal:  FASEB J       Date:  2009-10-13       Impact factor: 5.191

Review 10.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.